T2 Biosystems Q4 EPS $(1.41) Beats $(1.70) Estimate, Sales $5.48M Beat $5.40M Estimate
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(1.70) by 17.06 percent. This is a 59.71 percent increase over losses of $(3.50) per share from the
Nasdaq Surges 90 Points; Credo Technology Group Shares Slide
U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday.
The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to 12,050.47. The S&P 500 also rose, gaining, 0.16% to 4,142.69.
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 55.5% to $0.73 during Wednesday’s regular session. As of 12:30 EST, TransCode…
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Why T2 Biosystems Shares Are Nosediving
T2 Biosystems Inc (NASDAQ: TTOO) shares are trading lower by 21.43% to $1.10 Tuesday morning after the company announced a proposed public offering.
What Else?